Fed. Circ. Says Teva Can't Block Cenestin Generic
The Federal Circuit on Thursday ruled that Teva Women's Health Inc.'s decision to narrow the claims of a patent for the menopause drug Cenestin doomed its attempt to block Paddock Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article